Annual Cash & Cash Equivalents
$13.08 M
-$13.55 M-50.87%
31 December 2023
Summary:
NextCure annual cash & cash equivalents is currently $13.08 million, with the most recent change of -$13.55 million (-50.87%) on 31 December 2023. During the last 3 years, it has fallen by -$19.69 million (-60.08%). NXTC annual cash & cash equivalents is now -90.32% below its all-time high of $135.17 million, reached on 31 December 2018.NXTC Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$27.70 M
+$6.85 M+32.88%
30 September 2024
Summary:
NextCure quarterly cash and cash equivalents is currently $27.70 million, with the most recent change of +$6.85 million (+32.88%) on 30 September 2024. Over the past year, it has increased by +$8.18 million (+41.92%). NXTC quarterly cash and cash equivalents is now -85.62% below its all-time high of $192.69 million, reached on 30 June 2019.NXTC Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NXTC Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -50.9% | +41.9% |
| 3 y3 years | -60.1% | -24.4% |
| 5 y5 years | -90.3% | +178.8% |
NXTC Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -60.1% | +6.0% | -24.4% | +160.1% |
| 5 y | 5 years | -90.3% | +6.0% | -24.4% | +178.8% |
| alltime | all time | -90.3% | +55.2% | -85.6% | +178.8% |
NextCure Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $27.70 M(+32.9%) |
| June 2024 | - | $20.85 M(+13.6%) |
| Mar 2024 | - | $18.36 M(+40.3%) |
| Dec 2023 | $13.08 M(-50.9%) | $13.08 M(-33.0%) |
| Sept 2023 | - | $19.52 M(-11.4%) |
| June 2023 | - | $22.02 M(-26.5%) |
| Mar 2023 | - | $29.97 M(+12.6%) |
| Dec 2022 | $26.63 M(+115.9%) | $26.63 M(-14.2%) |
| Sept 2022 | - | $31.05 M(+10.3%) |
| June 2022 | - | $28.16 M(+164.4%) |
| Mar 2022 | - | $10.65 M(-13.7%) |
| Dec 2021 | $12.34 M | $12.34 M(-66.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $36.66 M(+5.0%) |
| June 2021 | - | $34.90 M(-4.4%) |
| Mar 2021 | - | $36.53 M(+11.5%) |
| Dec 2020 | $32.77 M(-3.9%) | $32.77 M(+45.4%) |
| Sept 2020 | - | $22.53 M(-10.0%) |
| June 2020 | - | $25.05 M(-13.3%) |
| Mar 2020 | - | $28.91 M(-15.2%) |
| Dec 2019 | $34.09 M(-74.8%) | $34.09 M(+243.1%) |
| Sept 2019 | - | $9.94 M(-94.8%) |
| June 2019 | - | $192.69 M(+53.5%) |
| Mar 2019 | - | $125.55 M(-7.1%) |
| Dec 2018 | $135.17 M(+1504.0%) | $135.17 M |
| Dec 2017 | $8.43 M | - |
FAQ
- What is NextCure annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for NextCure?
- What is NextCure annual cash & cash equivalents year-on-year change?
- What is NextCure quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for NextCure?
- What is NextCure quarterly cash and cash equivalents year-on-year change?
What is NextCure annual cash & cash equivalents?
The current annual cash & cash equivalents of NXTC is $13.08 M
What is the all time high annual cash & cash equivalents for NextCure?
NextCure all-time high annual cash & cash equivalents is $135.17 M
What is NextCure annual cash & cash equivalents year-on-year change?
Over the past year, NXTC annual cash & cash equivalents has changed by -$13.55 M (-50.87%)
What is NextCure quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of NXTC is $27.70 M
What is the all time high quarterly cash and cash equivalents for NextCure?
NextCure all-time high quarterly cash and cash equivalents is $192.69 M
What is NextCure quarterly cash and cash equivalents year-on-year change?
Over the past year, NXTC quarterly cash and cash equivalents has changed by +$8.18 M (+41.92%)